HIV/AIDS HAART
Free HAART increases probability of viral suppression at months 6 and 12
Published in AIDS Weekly, August 29th, 2005
"Despite the advent of effective combination antiretroviral drug therapy (ART) for the treatment of human immunodeficiency virus (HIV) infection, many doubt the feasibility of ART treatment programs in resource-poor settings. We performed a meta-analysis of the efficacy of ART programs in the developing world," scientists in the United States report.
"We searched the Medline database with the index terms 'HIV', 'antiretroviral therapy', 'CD4 count', 'viral load', 'experience', and 'outcomes'. A total of 201 abstracts were reviewed, and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2005-08-29)
More Articles from AIDS Weekly
- HIV/AIDS Diagnostics
Real-time RT-PCR diagnoses/monitors HIV-1 infection in resource-poor setting - HIV/AIDS Pathogenesis
Myeloid/plasmacytoid DCs transfer HIV-1 preferentially to Ag-specific CD4+ cells - HIV/AIDS Pathogenesis
Nanobacteria could promote genetic diversity in HIV - HIV/AIDS Research
Research shows random fluctuations in gene expression impacts HIV cells - HIV/AIDS Therapy
New approach has potential to treat latent HIV infection - Adverse Drug Reaction
Epidemiology study reports new info on hypersensitivity reactions to Abacavir - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
